Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Acorda, albeit, alcohol, allodynia, andrew, APIC, appraised, ascertain, Asia, Australia, Avanir, avoid, avoidance, avoiding, baclofen, BankAmerica, billed, blocking, Boulder, carisoprolol, category, cease, Cerebral, Chariman, chemotherapy, Claremont, clonazepam, coagulation, compliant, complication, composition, compound, concurrent, Conference, correspondingly, counteract, custodianship, cyclobenzaprine, Cymbalta, depression, diazepam, differentiate, dispute, disregarded, disrupt, disruptive, distort, diversify, domain, duloxetine, ease, edition, Eli, entitled, Error, estate, exaggerated, excitability, exit, explicit, facilitate, fill, filled, Flexeril, forNature, fulfill, furniture, gave, Genzyme, Germany, Guide, healing, hereditary, highlighted, Hutchinson, hypersensitivity, Importantly, impracticable, inconvenience, incremental, ingredient, inInternal, IRC, irreversible, Katharine, kind, King, legacy, Lilly, Linda, Lioresal, Lyrica, markedly, McKenna, McNeil, mentioned, metaxalone, mildly, mission, modification, motion, muscular, neuromuscular, Neuroscience, night, ninety, overuse, owe, page, Palsy, Parkway, Pepgen, percent, persuasive, pharmacodynamic, pharmacokinetic, Pharmazeutika, Physical, physicochemical, pool, poorly, PositionKenneth, potent, pregabalin, PrialtTM, prorated, recurrent, redundantly, rehabilitation, relax, relaxant, relay, reliant, reluctance, rental, resumption, Retail, routine, salary, Sanochemia, Sativex, sauter, SDI, sequence, shelf, shortening, shrinkage, Skelaxin, sleep, Soma, spasm, Spastic, spasticity, specialty, spin, stiff, stimulate, stretching, strikingly, strongly, sublicense, sublicensing, sudden, sum, synthetic, tendon, tizanidine, today, tolperisone, trasferred, trauma, undesirable, unearned, unexercised, uninterrupted, unpaid, unresolved, unused, upfront, uphold, vacancy, VII, violent, von, Wallace, widespread, Willebrand, wrote, Zanaflex
Removed:
AADC, abandon, Abbott, academic, accommodate, achieved, acting, affiliate, ago, Amgen, announced, assembled, authorization, bloodstream, brain, BTG, cardiac, Ceregene, cGMP, Chicago, Children, CHOP, chosen, chromatographic, closely, community, conform, converted, covered, covering, declined, designing, devoted, die, distribute, dog, dopamine, easily, efficient, elevation, employ, engineering, entail, entering, equivalent, event, expanded, exploring, expression, factual, failing, Florida, fluid, France, fundamental, GenVec, Gilford, Glenn, governed, Graduate, grew, healthy, helper, hematology, hemophilic, Hospital, immune, Immunology, improve, inexperience, infection, influenced, instrumental, interpret, interrupted, introduction, JHU, launch, Lawrence, lawsuit, LBL, licensee, light, listed, live, liver, Los, lose, Loyola, mice, mouse, move, natural, negotiated, neurobiology, Neurogen, NHF, notified, observed, pathogenic, pathology, peak, perception, Philadelphia, philip, Pierce, Planning, platform, Pompe, population, primate, Prizm, proceed, produced, Profit, progressed, prolonged, promote, protocol, proven, purification, putting, quickly, Quidel, rapid, reaction, reagent, realizing, regeneration, regulating, replicated, Reserve, residency, respond, retroviral, revoked, rigidity, scalable, SCID, secondary, selective, seminal, shared, show, simple, skeletal, skin, smaller, smooth, Squibb, St, steady, step, striatum, stricter, strike, submitting, suffer, supplying, timeframe, tissue, tolerated, toxicity, transduction, transfection, unaudited, understood, unsafe, unwanted, utilization, viral, Washington, Wharton, whitcome, workshop
Filing tables
Filing exhibits
Related press release
AVGN similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Reg. Nos. 333-12087, 333-68637, 333-94111, 333-42210, 333-56274, 333-90504 and 333-116740) pertaining to the 1993 Stock Option Plan, the Non-Statutory Stock Option, the 1996 Equity Incentive Plan, the 1996 Non-Employee Directors’ Stock Option Plan, the 1997 Employee Stock Purchase Plan, and the 2000 Equity Incentive Plan, and Registration Statements on Form S-3 (Reg. Nos. 333-68117, 333-72225, 333-79925, 333-92355 and 333-47680) and in the related Prospectuses of Avigen, Inc. of our reports dated March 10, 2005, with respect to the financial statements of Avigen, Inc., Avigen, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Avigen, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2005.
/s/ ERNST & YOUNG LLP
Palo Alto, California
March 14, 2006
March 14, 2006
1